Michael J. Sterns
Corporate Officer/Principal at Xenogen Corp.
Profile
Michael J.
Sterns is a professional with a background in business and corporate development.
He is currently the Chief Business Officer & Vice President at Xenogen Corp.
Prior to this, he served as the Executive Vice President at StemCor Systems, Inc. He has also held positions as the Head of Business Development at Telik, Inc. and as the Executive Vice President of Corporate Development at BioSpace, Inc. (Iowa).
Sterns received his undergraduate degree from the University of Southern California and his MBA and doctorate from the University of California, Berkeley.
Michael J. Sterns active positions
Companies | Position | Start |
---|---|---|
Xenogen Corp.
Xenogen Corp. Medical SpecialtiesHealth Technology Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA. | Corporate Officer/Principal | - |
Former positions of Michael J. Sterns
Companies | Position | End |
---|---|---|
StemCor Systems, Inc.
StemCor Systems, Inc. Medical SpecialtiesHealth Technology StemCor Systems, Inc. develops proprietary and minimally-invasive bone marrow collection systems for regenerative medicine. Its products include MarrowMiner System and MarrowSelect. The company was founded in June 2003 by Daniel Kraft and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | 2011-09-27 |
BioSpace, Inc. (Iowa)
BioSpace, Inc. (Iowa) Internet Software/ServicesTechnology Services BioSpace, Inc. operates as an online community for industry news and careers for life science professionals. It offers online job board, daily biotech news feeds, and community features connect recruiters, job seekers. The company was founded in March 1995 and is headquartered in Urbandale, IA. | Corporate Officer/Principal | 2002-11-30 |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | 2000-11-30 |
Training of Michael J. Sterns
University of Southern California | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Xenogen Corp.
Xenogen Corp. Medical SpecialtiesHealth Technology Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA. | Health Technology |
BioSpace, Inc. (Iowa)
BioSpace, Inc. (Iowa) Internet Software/ServicesTechnology Services BioSpace, Inc. operates as an online community for industry news and careers for life science professionals. It offers online job board, daily biotech news feeds, and community features connect recruiters, job seekers. The company was founded in March 1995 and is headquartered in Urbandale, IA. | Technology Services |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | Health Technology |
StemCor Systems, Inc.
StemCor Systems, Inc. Medical SpecialtiesHealth Technology StemCor Systems, Inc. develops proprietary and minimally-invasive bone marrow collection systems for regenerative medicine. Its products include MarrowMiner System and MarrowSelect. The company was founded in June 2003 by Daniel Kraft and is headquartered in Menlo Park, CA. | Health Technology |
- Stock Market
- Insiders
- Michael J. Sterns